Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva.

Organisations Organisation GeNeuro S.A. (Euronext Paris: GNRO)
  Organisation 2 GNEH S.A.S.
  Group Mérieux (Group)
Products Product temelimab (pHER-W Env MAb)
  Product 2 investment banking
Index term Index term GeNeuro–SEVERAL: investment, 202001 private placement €17.5m with 5.93m new shares at €2.95/share incl existent investor GNEH SAS
Persons Person Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO)
  Person 2 Bohin, Mathilde (NewCap 201809)
     


   
Record changed: 2020-02-12

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for GeNeuro S.A. (Euronext Paris: GNRO)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81




» top